Skip to main content

Bitterman Kevin's Form 4 filing

Disc Medicine, Inc. (IRON) · filed Dec 14, 2023

Accession no.
0001209191-23-058708
Filed
Dec 14, 2023
Trade date
Dec 12-14, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 11 non-derivative transactions. Open-market sales total $4.67M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Bitterman KevinCIK 0001591747Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 12, 2023Common StockSSaleDisposed−20,823$59.87F1−$1,246,673.01861,401Indirect
Dec 12, 2023Common StockSSaleDisposed−422$60.99F3−$25,737.78860,979Indirect
Dec 12, 2023Common StockSSaleDisposed−4,155$62.42F4−$259,355.1856,824Indirect
Dec 12, 2023Common StockSSaleDisposed−665$62.90F5−$41,828.5856,159Indirect
Dec 12, 2023Common StockSSaleDisposed−688$63.78F6−$43,880.64855,471Indirect
Dec 12, 2023Common StockSSaleDisposed−18,615$65.10F7−$1,211,836.5836,856Indirect
Dec 12, 2023Common StockSSaleDisposed−6,599$65.77F8−$434,016.23830,257Indirect
Dec 13, 2023Common StockSSaleDisposed−3,508$59.99F9−$210,444.92826,749Indirect
Dec 13, 2023Common StockSSaleDisposed−40$60.50−$2,420826,709Indirect
Dec 14, 2023Common StockSSaleDisposed−20,429$58.27F10−$1,190,397.83806,280Indirect
Dec 14, 2023Common StockSSaleDisposed−120$59.74F11−$7,168.8806,160Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.50 to $60.497 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), (4), (5), (6), (7), (8), (9), (10) and (11).

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.51 to $61.50 inclusive.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.5297 to $62.5175 inclusive.

Referenced by the price of 1 transaction in Table I.

F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.6436 to $63.3256 inclusive.

Referenced by the price of 1 transaction in Table I.

F6

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.70 to $64.67 inclusive.

Referenced by the price of 1 transaction in Table I.

F7

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.7499 to $65.735 inclusive.

Referenced by the price of 1 transaction in Table I.

F8

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.745 to $66.32 inclusive.

Referenced by the price of 1 transaction in Table I.

F9

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.50 to $60.4381 inclusive.

Referenced by the price of 1 transaction in Table I.

F10

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.25 to $58.65 inclusive.

Referenced by the price of 1 transaction in Table I.

F11

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.53 to $60.17 inclusive.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)